| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A note on improved statistical approaches to account for pseudoprogression
|
Abrouk, Nacer
|
|
2018
|
81 |
3 |
p. 621-626
|
artikel
|
| 2 |
A phase I dose escalation trial of nab-paclitaxel and fixed dose radiation in patients with unresectable or borderline resectable pancreatic cancer
|
Shabason, Jacob E.
|
|
2018
|
81 |
3 |
p. 609-614
|
artikel
|
| 3 |
A phase I study for adjuvant chemotherapy of gemcitabine plus S-1 in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1202)
|
Yanagimoto, Hiroaki
|
|
2018
|
81 |
3 |
p. 461-468
|
artikel
|
| 4 |
A phase I study of intravenous artesunate in patients with advanced solid tumor malignancies
|
Deeken, John F.
|
|
2018
|
81 |
3 |
p. 587-596
|
artikel
|
| 5 |
A randomised trial comparing the pharmacokinetics and safety of the biosimilar CT-P6 with reference trastuzumab
|
Esteva, Francisco J.
|
|
2018
|
81 |
3 |
p. 505-514
|
artikel
|
| 6 |
Cellular pharmacology studies of anticancer agents: recommendations from the EORTC-PAMM group
|
Perego, Paola
|
|
2017
|
81 |
3 |
p. 427-441
|
artikel
|
| 7 |
Combinatorial effects of histone deacetylase inhibitors (HDACi), vorinostat and entinostat, and adaphostin are characterized by distinct redox alterations
|
Rivera-Del Valle, Nilsa
|
|
2018
|
81 |
3 |
p. 483-495
|
artikel
|
| 8 |
Comparative assessment of pharmacokinetics, and pharmacodynamics between RTXM83™, a rituximab biosimilar, and rituximab in diffuse large B-cell lymphoma patients: a population PK model approach
|
Candelaria, Myrna
|
|
2018
|
81 |
3 |
p. 515-527
|
artikel
|
| 9 |
2-Deoxy-d-glucose enhances TRAIL-induced apoptosis in human gastric cancer cells through downregulating JNK-mediated cytoprotective autophagy
|
Xu, Yuting
|
|
2018
|
81 |
3 |
p. 555-564
|
artikel
|
| 10 |
Docetaxel, cisplatin and S-1 (DCS) combination chemotherapy for gastric cancer patients with peritoneal metastasis: a retrospective study
|
Ohnuma, Hiroyuki
|
|
2018
|
81 |
3 |
p. 539-548
|
artikel
|
| 11 |
Effects of posaconazole (a strong CYP3A4 inhibitor), two new tablet formulations, and food on the pharmacokinetics of idasanutlin, an MDM2 antagonist, in patients with advanced solid tumors
|
Nemunaitis, John
|
|
2018
|
81 |
3 |
p. 529-537
|
artikel
|
| 12 |
First-line therapy for advanced non-small cell lung cancer with activating EGFR mutation: is combined EGFR-TKIs and chemotherapy a better choice?
|
Wang, Shuyun
|
|
2018
|
81 |
3 |
p. 443-453
|
artikel
|
| 13 |
Long-term results of S-1 plus cisplatin with concurrent thoracic radiotherapy for locally advanced non-small-cell lung cancer
|
Taira, Tetsuhiko
|
|
2018
|
81 |
3 |
p. 565-572
|
artikel
|
| 14 |
Multicenter retrospective study of cetuximab plus platinum-based chemotherapy for recurrent or metastatic oral squamous cell carcinoma
|
Yanamoto, Souichi
|
|
2018
|
81 |
3 |
p. 549-554
|
artikel
|
| 15 |
Pharmacokinetics of dacarbazine (DTIC) in pregnancy
|
Kantrowitz-Gordon, Ira
|
|
2018
|
81 |
3 |
p. 455-460
|
artikel
|
| 16 |
Phase 1 summary of plasma concentration–QTc analysis for idasanutlin, an MDM2 antagonist, in patients with advanced solid tumors and AML
|
Blotner, Steven
|
|
2018
|
81 |
3 |
p. 597-607
|
artikel
|
| 17 |
Rabdocoestin B exhibits antitumor activity by inducing G2/M phase arrest and apoptosis in esophageal squamous cell carcinoma
|
Wang, Jingnan
|
|
2018
|
81 |
3 |
p. 469-481
|
artikel
|
| 18 |
Retraction Note to: Quinoxaline 1,4-dioxides induce G2/M cell cycle arrest and apoptosis in human colon cancer cells
|
Gali-Muhtasib, Hala U.
|
|
2018
|
81 |
3 |
p. 627
|
artikel
|
| 19 |
Role of TPMT and ITPA variants in mercaptopurine disposition
|
Gerbek, Tina
|
|
2018
|
81 |
3 |
p. 579-586
|
artikel
|
| 20 |
S-1 (Teysuno) and gemcitabine in Caucasian patients with unresectable pancreatic adenocarcinoma
|
Winther, Stine Braendegaard
|
|
2018
|
81 |
3 |
p. 573-578
|
artikel
|
| 21 |
The effect of food on the pharmacokinetics of niraparib, a poly(ADP-ribose) polymerase (PARP) inhibitor, in patients with recurrent ovarian cancer
|
Moore, Kathleen
|
|
2018
|
81 |
3 |
p. 497-503
|
artikel
|
| 22 |
Vitamin D pathway gene polymorphisms and hepatocellular carcinoma in chronic hepatitis C-affected patients treated with new drugs
|
Cusato, Jessica
|
|
2018
|
81 |
3 |
p. 615-620
|
artikel
|
Tijdschrift beschrijving